JP2022549680A5 - - Google Patents
Info
- Publication number
- JP2022549680A5 JP2022549680A5 JP2022519131A JP2022519131A JP2022549680A5 JP 2022549680 A5 JP2022549680 A5 JP 2022549680A5 JP 2022519131 A JP2022519131 A JP 2022519131A JP 2022519131 A JP2022519131 A JP 2022519131A JP 2022549680 A5 JP2022549680 A5 JP 2022549680A5
- Authority
- JP
- Japan
- Prior art keywords
- dendrimer
- group
- composition
- building unit
- peg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019903628 | 2019-09-26 | ||
| AU2019903628A AU2019903628A0 (en) | 2019-09-26 | Therapeutic Dendrimer | |
| AU2019904094A AU2019904094A0 (en) | 2019-10-30 | Therapeutic dendrimer | |
| AU2019904094 | 2019-10-30 | ||
| PCT/AU2020/051028 WO2021056077A1 (en) | 2019-09-26 | 2020-09-25 | Therapeutic dendrimer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022549680A JP2022549680A (ja) | 2022-11-28 |
| JP2022549680A5 true JP2022549680A5 (OSRAM) | 2023-10-02 |
Family
ID=75164741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519131A Pending JP2022549680A (ja) | 2019-09-26 | 2020-09-25 | 治療用デンドリマー |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12616711B2 (OSRAM) |
| EP (1) | EP4034169B1 (OSRAM) |
| JP (1) | JP2022549680A (OSRAM) |
| KR (1) | KR20220072851A (OSRAM) |
| CN (1) | CN114585389A (OSRAM) |
| AU (1) | AU2020354787A1 (OSRAM) |
| CA (1) | CA3152111A1 (OSRAM) |
| WO (1) | WO2021056077A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180326081A1 (en) * | 2011-06-06 | 2018-11-15 | Starpharma Pty Ltd | Macromolecules |
| JP7550149B2 (ja) | 2018-11-20 | 2024-09-12 | スターファーマ ピーティーワイ エルティーディー | 治療用デンドリマー |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7261875B2 (en) * | 2001-12-21 | 2007-08-28 | Board Of Regents, The University Of Texas System | Dendritic poly (amino acid) carriers and methods of use |
| AR042042A1 (es) * | 2002-11-15 | 2005-06-08 | Sugen Inc | Administracion combinada de una indolinona con un agente quimioterapeutico para trastornos de proliferacion celular |
| CA2626865C (en) | 2005-10-25 | 2014-12-30 | Starpharma Pty Limited | Macromolecular compounds having controlled stoichiometry |
| CN101420962A (zh) | 2006-01-20 | 2009-04-29 | 星药股份有限公司 | 经修饰的大分子 |
| US9173953B2 (en) | 2009-07-31 | 2015-11-03 | Ascendis Pharma As | Prodrugs containing an aromatic amine connected by an amido bond to a linker |
| BR112013031556B1 (pt) * | 2011-06-06 | 2022-03-29 | Starpharma Pty Ltd | Macromoléculas, uso das mesmas para tratar ou suprimir o crescimento de um câncer e composições farmacêuticas |
| US20180326081A1 (en) | 2011-06-06 | 2018-11-15 | Starpharma Pty Ltd | Macromolecules |
| GB2551979A (en) * | 2016-06-30 | 2018-01-10 | Rs Arastirma Egitim Danismanlik Llac Sanayi Ticaret Ltd | Cleavable polymer drug conjugates |
| TWI773730B (zh) * | 2017-02-22 | 2022-08-11 | 瑞典商阿斯特捷利康公司 | 治療性樹枝狀聚合物 |
| CA3106568A1 (en) | 2018-07-19 | 2020-01-23 | Starpharma Pty Ltd | Therapeutic dendrimer |
| JP7550149B2 (ja) * | 2018-11-20 | 2024-09-12 | スターファーマ ピーティーワイ エルティーディー | 治療用デンドリマー |
| EP3886912A4 (en) * | 2018-11-29 | 2023-01-04 | Starpharma Pty Limited | DENDRIMER FOR THERAPY AND IMAGING |
-
2020
- 2020-09-25 WO PCT/AU2020/051028 patent/WO2021056077A1/en not_active Ceased
- 2020-09-25 EP EP20869915.7A patent/EP4034169B1/en active Active
- 2020-09-25 CA CA3152111A patent/CA3152111A1/en active Pending
- 2020-09-25 KR KR1020227013430A patent/KR20220072851A/ko not_active Ceased
- 2020-09-25 JP JP2022519131A patent/JP2022549680A/ja active Pending
- 2020-09-25 CN CN202080072371.4A patent/CN114585389A/zh active Pending
- 2020-09-25 AU AU2020354787A patent/AU2020354787A1/en active Pending
- 2020-09-25 US US17/763,887 patent/US12616711B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Venditto et al. | Cancer therapies utilizing the camptothecins: a review of the in vivo literature | |
| Sun et al. | Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy | |
| JP2010540535A5 (OSRAM) | ||
| JP2012532185A5 (OSRAM) | ||
| EP3352796B1 (en) | Drug formulation based on particulates comprising polysaccharide-vitamin conjugate | |
| RU2012151134A (ru) | Логометрическая комбинаторная доставка лекарственных средств | |
| JP2020503289A5 (OSRAM) | ||
| Nguyen et al. | Curcumin and paclitaxel co-loaded heparin and poloxamer p403 hybrid nanocarrier for improved synergistic efficacy in breast cancer | |
| TW200803842A (en) | Antineoplastic combinations of temsirolimus and sunitinib malate | |
| ES2744975T3 (es) | Método de dosificación metronómica con profármacos de camptotecina (p. ej. PEG-Irinotecán) | |
| US20190091152A1 (en) | Use of umirolimus and its derivatives for treating cancer | |
| US20120015900A1 (en) | Cobalamin Taxane Bioconjugates | |
| JP2018536655A5 (OSRAM) | ||
| WO2014084378A1 (ja) | 環状ｒｇｄ配列含有ペプチドを含む抗癌剤 | |
| Yadav et al. | Innovative nanoparticulate strategies in colon cancer treatment: a paradigm shift | |
| ES2358493B1 (es) | Nanopartículas pegiladas que comprenden una molécula biológicamente activa y sus aplicaciones. | |
| CN116133693A (zh) | 载药的大分子及其制备方法 | |
| WO2018049017A1 (en) | Block copolymer systems for local administration of toll-like receptor agonists | |
| CN115844822A (zh) | 一种口服载药胶束组合物及其制备方法 | |
| CN119950749A (zh) | 基于聚合物的大分子前药 | |
| US12616711B2 (en) | Therapeutic dendrimer | |
| JP6580030B2 (ja) | カンプトテシン誘導体とｈｓｐ９０阻害剤の結合した高分子化合物及びその用途 | |
| JP6461088B2 (ja) | 高分子化カンプトテシン誘導体及び高分子化ｈｓｐ９０阻害剤誘導体を含む医薬組成物 | |
| Hu et al. | Current status of CPT and its analogues in the treatment of malignancies | |
| CN104689336A (zh) | 医药组合物或组合剂 |